In a surprising revelation, Raiders veteran Adam Butler addresses the release of Christian Wilkins, emphasizing the importance of mental health and the need for athletes to seek help during tough times.
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
Before you become a parent, you hear about sleepless nights and busy days, but no one warns you about the injuries. Discover why new parents face surprising orthopedic issues and how to stay healthy while caring for kids!
A prostate cancer survivor shares the unexpected challenges of life after treatment, from physical recovery to emotional struggles, revealing the realities that many face on the road to healing.
Doctors are pushing the FDA to remove black box warnings on low-dose estrogen treatments, arguing it discourages women from beneficial hormone therapies for menopause. Experts claim the risks are overstated and can hinder treatment.
Christopher Kennedy's unexpected diagnosis of idiopathic pulmonary fibrosis transformed his life. As he faced deteriorating health, a double-lung transplant became his beacon of hope, leading to a remarkable recovery and a renewed appreciation for life.
As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
